Metabolic syndrome and incident diabetes

Diabetes Care

Volumn 31, Issue 9, 2008, Pages 1898-1904

  Ford, Earl S ^a   Li, Chaoyang ^a   Sattar, Naveed ^b  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; PREDICTION; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR; WORLD HEALTH ORGANIZATION; COHORT ANALYSIS; ETHNIC GROUP; NON INSULIN DEPENDENT DIABETES MELLITUS; RACE; REVIEW; STATISTICS;

COHORT STUDIES; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; HUMANS; METABOLIC SYNDROME X;

EID: 53049108337     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0423     Document Type: Article

References (40)

1. Ford ES: Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28:1769-1778, 2005
2. World Health Organization: Definition, diagnosis, and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part I: diagnosis and classification of diabetes mellitus. Geneva, World Health Org., 1999 (WHO/NCO/NCS/99.2)
3. Balkau B, Charles MA: Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16: 442-443, 1999
4. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
5. Grundy SM, Brewer HB, Jr, Cleeman JI, Smith SC, Jr, Lenfant C: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433-438, 2004
6. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome-a new worldwide definition. Lancet 366:1059-1062, 2005
7. Grundy SM, Cleeman JI, Daniels SR, Do- nato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752, 2005
8. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414-419, 2003
9. Lim HS, Lip GY, Beevers DG, Blann AD: Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension. Eur J Clin Invest 35:324-329, 2005
10. Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Fra- mingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch 1ntern Med 165:2644-2650, 2005
11. Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49:403-414, 2007
12. Wang JJ, Hu G, Miettinen ME, Tuom- ilehto J: The metabolic syndrome and incident diabetes: assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial glucose. Horm Metab Res 36:708-715, 2004
13. Wang JJ, Li HB, Kinnunen L, Hu G, Jarvi- nen TM, Miettinen ME, Yuan S, Tuom- ilehto J: How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population? Atherosclerosis 192:161-168, 2007
14. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
15. Greenland S: Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9:1-30:1-30, 1987
16. Tobias A: Assessing the influence of a single study in meta-analysis. Stata Tech Bull 47:15-17, 1999
17. Egger M, Davey SG, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634, 1997
18. Hanson RL, Imperatore G, Bennett PH, Knowler WC: Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51:3120-3127, 2002
19. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, Howard BV: Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 26:861-867, 2003
20. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM: The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26: 3153-3159, 2003
21. Stern MP, Williams K, Gonzalez-Villal- pando C, Hunt KJ, Haffner SM: Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 27:2676-2681, 2004
22. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072, 2005
23. HanleyAJ, Karter AJ, Williams K, FestaA, D'Agostino RB, Jr, Wagenknecht LE, Haffner SM: Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study. Circulation 112:3713-3721, 2005
24. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB: Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91: 2906-2912, 2006
25. Lorenzo C, Williams K, Hunt KJ, Haffner SM: The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndromeas predictors of incident cardiovascular disease and diabetes. Diabetes Care 30: 8-13, 2007
26. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D'Agostino RB, Sr, Wilson PW: Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 30:1219-1225, 2007
27. Cheung BM, Wat NM, Man YB, Tam S, Thomas GN, Leung GM, Cheng CH, Woo J, Janus ED, Lau CP, Lam TH, Lam KS: Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 30:1430-1436, 2007
28. Elwood PC, Pickering JE, Fehily AM: Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J Epidemiol Community Health 61:695-698, 2007
29. Cameron AJ, Zimmet PZ, Soderberg S, Al- berti KG, Sicree R, Tuomilehto J, Chitson P, Shaw JE: The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius. Diabet Med 24:1460-1469, 2007
30. Mannucci E, Monami M, Cresci B, Pala L, Bardini G, Petracca MG, Dicembrini I, Pasqua A, Buiatti E, Rotella CM: National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study. Diabetes Obes Metab 10:430-435, 2008
31. Cameron AJ, Magliano DJ, Zimmet PZ, Welborn TA, Colagiuri S, Tonkin AM, Shaw JE: The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med Epub ahead of print, 2008
32. Hadaegh F, Ghasemi A, Padyab M, To- hidi M, Azizi F: The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes Res Clin Pract 80:328 - 334, 2008
33. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA: Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 156:1070-1077, 2002
34. Onat A, Hergenc G, Keles I, Dogan Y, Turkmen S, Sansoy V: Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome. Metabolism 54: 800 -808, 2005
35. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE: Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 28:2013-2018, 2005
36. Klein BE, Klein R, Lee KE: Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 25:1790-1794, 2002
37. Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136: 575-581, 2002
38. Lindstrom J, Tuomilehto J: The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725-731, 2003
39. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Mohlig M, Pfeiffer AF, Spranger J, Thamer C, Haring HU, Fritsche A, Joost HG: An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 30:510-515, 2007
40. Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, Marfisi R, Scarano M, Tavazzi L, Tognoni G, Vala- gussa F, Marchioli R: A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Preven- zione scoring. Am Heart J 151:754,2006